BlackRock Health Sciences Trust (NYSE:BME) Shares Purchased by Wells Fargo & Company MN

Wells Fargo & Company MN grew its stake in shares of BlackRock Health Sciences Trust (NYSE:BMEFree Report) by 10.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 393,056 shares of the company’s stock after purchasing an additional 37,555 shares during the period. Wells Fargo & Company MN’s holdings in BlackRock Health Sciences Trust were worth $15,903,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Janney Montgomery Scott LLC increased its stake in BlackRock Health Sciences Trust by 2.2% in the 3rd quarter. Janney Montgomery Scott LLC now owns 24,906 shares of the company’s stock valued at $975,000 after purchasing an additional 525 shares in the last quarter. UBS Group AG increased its position in shares of BlackRock Health Sciences Trust by 35.0% in the third quarter. UBS Group AG now owns 114,996 shares of the company’s stock valued at $4,502,000 after buying an additional 29,793 shares in the last quarter. Invesco Ltd. raised its stake in shares of BlackRock Health Sciences Trust by 20.9% during the 3rd quarter. Invesco Ltd. now owns 184,517 shares of the company’s stock worth $7,224,000 after buying an additional 31,953 shares during the last quarter. Consolidated Portfolio Review Corp grew its stake in BlackRock Health Sciences Trust by 36.0% in the 3rd quarter. Consolidated Portfolio Review Corp now owns 9,067 shares of the company’s stock valued at $355,000 after acquiring an additional 2,400 shares during the last quarter. Finally, 1607 Capital Partners LLC acquired a new stake in BlackRock Health Sciences Trust in the 3rd quarter valued at about $3,449,000.

BlackRock Health Sciences Trust Stock Performance

Shares of BME opened at $39.87 on Friday. The company has a 50-day moving average of $39.82 and a two-hundred day moving average of $40.42. BlackRock Health Sciences Trust has a 12-month low of $35.53 and a 12-month high of $42.86.

BlackRock Health Sciences Trust Dividend Announcement

The business also recently announced a monthly dividend, which was paid on Friday, May 31st. Investors of record on Wednesday, May 15th were paid a $0.213 dividend. This represents a $2.56 dividend on an annualized basis and a yield of 6.41%. The ex-dividend date of this dividend was Tuesday, May 14th.

BlackRock Health Sciences Trust Company Profile

(Free Report)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Read More

Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BMEFree Report).

Institutional Ownership by Quarter for BlackRock Health Sciences Trust (NYSE:BME)

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.